ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Eye Drops (Artificial Tear) Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-1O12849
Home | Market Reports | Health| Vision Care
Global Eye Drops Artificial Tear Market Research Report 2022
BUY CHAPTERS

Global Eye Drops (Artificial Tear) Market Research Report 2025

Code: QYRE-Auto-1O12849
Report
February 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Santen Pharma
Johnson & Johnson
Thea Pharmaceuticals
Ursapharm
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
Alcon
Allergan plc
Bausch & Lomb

Eye Drops (Artificial Tear) Market Size

The global market for Eye Drops (Artificial Tear) was valued at US$ 3399 million in the year 2024 and is projected to reach a revised size of US$ 4367 million by 2031, growing at a CAGR of 3.7% during the forecast period.

Eye Drops (Artificial Tear) Market

Eye Drops (Artificial Tear) Market

Lubricant eye drops used to treat the dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations.
The artificial tears and lubricants market is driven by the increasing prevalence of dry eye syndrome and the growing awareness of the importance of ocular health. Artificial tears and lubricants are eye drops and ointments used to alleviate dryness and discomfort in the eyes caused by various factors, including aging, digital device use, and environmental conditions. The rise in the aging population and the prevalence of conditions like Sjögren"s syndrome contribute to market growth as artificial tears provide relief and improve ocular surface health. Moreover, advancements in formulation technology and the development of preservative-free and longer-lasting products have enhanced their efficacy and patient compliance. However, the market also faces challenges, including the need for proper diagnosis and patient education to ensure appropriate product selection and usage. Additionally, addressing competition from alternative dry eye treatments and maintaining affordable pricing can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and effective artificial tears and lubricants, collaborate with eye care professionals to promote their benefits, and address the challenges to meet the increasing demand for ocular health solutions.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Eye Drops (Artificial Tear), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eye Drops (Artificial Tear).
The Eye Drops (Artificial Tear) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Eye Drops (Artificial Tear) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eye Drops (Artificial Tear) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Eye Drops (Artificial Tear) Market Report

Report Metric Details
Report Name Eye Drops (Artificial Tear) Market
Accounted market size in year US$ 3399 million
Forecasted market size in 2031 US$ 4367 million
CAGR 3.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Pharmacy
  • Internet
  • Grocery
  • Optical Chains
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, Bausch & Lomb, Thea pharmaceuticals, URSAPHARM, SIMILASAN, Akorn, United Laboratories, Sun Pharmaceutical, Jianfeng Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Eye Drops (Artificial Tear) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Eye Drops (Artificial Tear) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Eye Drops (Artificial Tear) Market growing?

Ans: The Eye Drops (Artificial Tear) Market witnessing a CAGR of 3.7% during the forecast period 2025-2031.

What is the Eye Drops (Artificial Tear) Market size in 2031?

Ans: The Eye Drops (Artificial Tear) Market size in 2031 will be US$ 4367 million.

Who are the main players in the Eye Drops (Artificial Tear) Market report?

Ans: The main players in the Eye Drops (Artificial Tear) Market are Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, Bausch & Lomb, Thea pharmaceuticals, URSAPHARM, SIMILASAN, Akorn, United Laboratories, Sun Pharmaceutical, Jianfeng Group

What are the Application segmentation covered in the Eye Drops (Artificial Tear) Market report?

Ans: The Applications covered in the Eye Drops (Artificial Tear) Market report are Pharmacy, Internet, Grocery, Optical Chains

What are the Type segmentation covered in the Eye Drops (Artificial Tear) Market report?

Ans: The Types covered in the Eye Drops (Artificial Tear) Market report are Allergy Eye Care, Standard Eye Care

Recommended Reports

Dry Eye Treatments

Ophthalmic Eye Drops

Eye Health Devices

1 Eye Drops (Artificial Tear) Market Overview
1.1 Product Definition
1.2 Eye Drops (Artificial Tear) by Type
1.2.1 Global Eye Drops (Artificial Tear) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Allergy Eye Care
1.2.3 Standard Eye Care
1.3 Eye Drops (Artificial Tear) by Application
1.3.1 Global Eye Drops (Artificial Tear) Market Value by Application (2024 VS 2031)
1.3.2 Pharmacy
1.3.3 Internet
1.3.4 Grocery
1.3.5 Optical Chains
1.4 Global Eye Drops (Artificial Tear) Market Size Estimates and Forecasts
1.4.1 Global Eye Drops (Artificial Tear) Revenue 2020-2031
1.4.2 Global Eye Drops (Artificial Tear) Sales 2020-2031
1.4.3 Global Eye Drops (Artificial Tear) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Eye Drops (Artificial Tear) Market Competition by Manufacturers
2.1 Global Eye Drops (Artificial Tear) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Eye Drops (Artificial Tear) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Eye Drops (Artificial Tear) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Eye Drops (Artificial Tear), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Eye Drops (Artificial Tear), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Eye Drops (Artificial Tear), Product Type & Application
2.7 Global Key Manufacturers of Eye Drops (Artificial Tear), Date of Enter into This Industry
2.8 Global Eye Drops (Artificial Tear) Market Competitive Situation and Trends
2.8.1 Global Eye Drops (Artificial Tear) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Eye Drops (Artificial Tear) Players Market Share by Revenue
2.8.3 Global Eye Drops (Artificial Tear) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Eye Drops (Artificial Tear) Market Scenario by Region
3.1 Global Eye Drops (Artificial Tear) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Eye Drops (Artificial Tear) Sales by Region: 2020-2031
3.2.1 Global Eye Drops (Artificial Tear) Sales by Region: 2020-2025
3.2.2 Global Eye Drops (Artificial Tear) Sales by Region: 2026-2031
3.3 Global Eye Drops (Artificial Tear) Revenue by Region: 2020-2031
3.3.1 Global Eye Drops (Artificial Tear) Revenue by Region: 2020-2025
3.3.2 Global Eye Drops (Artificial Tear) Revenue by Region: 2026-2031
3.4 North America Eye Drops (Artificial Tear) Market Facts & Figures by Country
3.4.1 North America Eye Drops (Artificial Tear) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Eye Drops (Artificial Tear) Sales by Country (2020-2031)
3.4.3 North America Eye Drops (Artificial Tear) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Eye Drops (Artificial Tear) Market Facts & Figures by Country
3.5.1 Europe Eye Drops (Artificial Tear) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Eye Drops (Artificial Tear) Sales by Country (2020-2031)
3.5.3 Europe Eye Drops (Artificial Tear) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Eye Drops (Artificial Tear) Market Facts & Figures by Region
3.6.1 Asia Pacific Eye Drops (Artificial Tear) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Eye Drops (Artificial Tear) Sales by Region (2020-2031)
3.6.3 Asia Pacific Eye Drops (Artificial Tear) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Eye Drops (Artificial Tear) Market Facts & Figures by Country
3.7.1 Latin America Eye Drops (Artificial Tear) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Eye Drops (Artificial Tear) Sales by Country (2020-2031)
3.7.3 Latin America Eye Drops (Artificial Tear) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Eye Drops (Artificial Tear) Market Facts & Figures by Country
3.8.1 Middle East and Africa Eye Drops (Artificial Tear) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Eye Drops (Artificial Tear) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Eye Drops (Artificial Tear) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Eye Drops (Artificial Tear) Sales by Type (2020-2031)
4.1.1 Global Eye Drops (Artificial Tear) Sales by Type (2020-2025)
4.1.2 Global Eye Drops (Artificial Tear) Sales by Type (2026-2031)
4.1.3 Global Eye Drops (Artificial Tear) Sales Market Share by Type (2020-2031)
4.2 Global Eye Drops (Artificial Tear) Revenue by Type (2020-2031)
4.2.1 Global Eye Drops (Artificial Tear) Revenue by Type (2020-2025)
4.2.2 Global Eye Drops (Artificial Tear) Revenue by Type (2026-2031)
4.2.3 Global Eye Drops (Artificial Tear) Revenue Market Share by Type (2020-2031)
4.3 Global Eye Drops (Artificial Tear) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Eye Drops (Artificial Tear) Sales by Application (2020-2031)
5.1.1 Global Eye Drops (Artificial Tear) Sales by Application (2020-2025)
5.1.2 Global Eye Drops (Artificial Tear) Sales by Application (2026-2031)
5.1.3 Global Eye Drops (Artificial Tear) Sales Market Share by Application (2020-2031)
5.2 Global Eye Drops (Artificial Tear) Revenue by Application (2020-2031)
5.2.1 Global Eye Drops (Artificial Tear) Revenue by Application (2020-2025)
5.2.2 Global Eye Drops (Artificial Tear) Revenue by Application (2026-2031)
5.2.3 Global Eye Drops (Artificial Tear) Revenue Market Share by Application (2020-2031)
5.3 Global Eye Drops (Artificial Tear) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Company Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Allergan Eye Drops (Artificial Tear) Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Alcon
6.2.1 Alcon Company Information
6.2.2 Alcon Description and Business Overview
6.2.3 Alcon Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Alcon Eye Drops (Artificial Tear) Product Portfolio
6.2.5 Alcon Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Company Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis Eye Drops (Artificial Tear) Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Santen Pharma
6.4.1 Santen Pharma Company Information
6.4.2 Santen Pharma Description and Business Overview
6.4.3 Santen Pharma Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Santen Pharma Eye Drops (Artificial Tear) Product Portfolio
6.4.5 Santen Pharma Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Company Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Johnson & Johnson Eye Drops (Artificial Tear) Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Bausch & Lomb
6.6.1 Bausch & Lomb Company Information
6.6.2 Bausch & Lomb Description and Business Overview
6.6.3 Bausch & Lomb Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bausch & Lomb Eye Drops (Artificial Tear) Product Portfolio
6.6.5 Bausch & Lomb Recent Developments/Updates
6.7 Thea pharmaceuticals
6.7.1 Thea pharmaceuticals Company Information
6.7.2 Thea pharmaceuticals Description and Business Overview
6.7.3 Thea pharmaceuticals Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Thea pharmaceuticals Eye Drops (Artificial Tear) Product Portfolio
6.7.5 Thea pharmaceuticals Recent Developments/Updates
6.8 URSAPHARM
6.8.1 URSAPHARM Company Information
6.8.2 URSAPHARM Description and Business Overview
6.8.3 URSAPHARM Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 URSAPHARM Eye Drops (Artificial Tear) Product Portfolio
6.8.5 URSAPHARM Recent Developments/Updates
6.9 SIMILASAN
6.9.1 SIMILASAN Company Information
6.9.2 SIMILASAN Description and Business Overview
6.9.3 SIMILASAN Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 SIMILASAN Eye Drops (Artificial Tear) Product Portfolio
6.9.5 SIMILASAN Recent Developments/Updates
6.10 Akorn
6.10.1 Akorn Company Information
6.10.2 Akorn Description and Business Overview
6.10.3 Akorn Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Akorn Eye Drops (Artificial Tear) Product Portfolio
6.10.5 Akorn Recent Developments/Updates
6.11 United Laboratories
6.11.1 United Laboratories Company Information
6.11.2 United Laboratories Description and Business Overview
6.11.3 United Laboratories Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 United Laboratories Eye Drops (Artificial Tear) Product Portfolio
6.11.5 United Laboratories Recent Developments/Updates
6.12 Sun Pharmaceutical
6.12.1 Sun Pharmaceutical Company Information
6.12.2 Sun Pharmaceutical Description and Business Overview
6.12.3 Sun Pharmaceutical Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sun Pharmaceutical Eye Drops (Artificial Tear) Product Portfolio
6.12.5 Sun Pharmaceutical Recent Developments/Updates
6.13 Jianfeng Group
6.13.1 Jianfeng Group Company Information
6.13.2 Jianfeng Group Description and Business Overview
6.13.3 Jianfeng Group Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Jianfeng Group Eye Drops (Artificial Tear) Product Portfolio
6.13.5 Jianfeng Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Eye Drops (Artificial Tear) Industry Chain Analysis
7.2 Eye Drops (Artificial Tear) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Eye Drops (Artificial Tear) Production Mode & Process Analysis
7.4 Eye Drops (Artificial Tear) Sales and Marketing
7.4.1 Eye Drops (Artificial Tear) Sales Channels
7.4.2 Eye Drops (Artificial Tear) Distributors
7.5 Eye Drops (Artificial Tear) Customer Analysis
8 Eye Drops (Artificial Tear) Market Dynamics
8.1 Eye Drops (Artificial Tear) Industry Trends
8.2 Eye Drops (Artificial Tear) Market Drivers
8.3 Eye Drops (Artificial Tear) Market Challenges
8.4 Eye Drops (Artificial Tear) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
Santen Pharma
Johnson & Johnson
Thea Pharmaceuticals
Ursapharm
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
Alcon
Allergan plc
Bausch & Lomb
List of Tables
 Table 1. Global Eye Drops (Artificial Tear) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Eye Drops (Artificial Tear) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Eye Drops (Artificial Tear) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Eye Drops (Artificial Tear) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Eye Drops (Artificial Tear) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Eye Drops (Artificial Tear) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Eye Drops (Artificial Tear) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Eye Drops (Artificial Tear) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Eye Drops (Artificial Tear), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Eye Drops (Artificial Tear), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Eye Drops (Artificial Tear), Product Type & Application
 Table 12. Global Key Manufacturers of Eye Drops (Artificial Tear), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Eye Drops (Artificial Tear) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eye Drops (Artificial Tear) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Eye Drops (Artificial Tear) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Eye Drops (Artificial Tear) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Eye Drops (Artificial Tear) Sales Market Share by Region (2020-2025)
 Table 19. Global Eye Drops (Artificial Tear) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Eye Drops (Artificial Tear) Sales Market Share by Region (2026-2031)
 Table 21. Global Eye Drops (Artificial Tear) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Eye Drops (Artificial Tear) Revenue Market Share by Region (2020-2025)
 Table 23. Global Eye Drops (Artificial Tear) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Eye Drops (Artificial Tear) Revenue Market Share by Region (2026-2031)
 Table 25. North America Eye Drops (Artificial Tear) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Eye Drops (Artificial Tear) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Eye Drops (Artificial Tear) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Eye Drops (Artificial Tear) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Eye Drops (Artificial Tear) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Eye Drops (Artificial Tear) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Eye Drops (Artificial Tear) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Eye Drops (Artificial Tear) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Eye Drops (Artificial Tear) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Eye Drops (Artificial Tear) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Eye Drops (Artificial Tear) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Eye Drops (Artificial Tear) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Eye Drops (Artificial Tear) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Eye Drops (Artificial Tear) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Eye Drops (Artificial Tear) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Eye Drops (Artificial Tear) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Eye Drops (Artificial Tear) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Eye Drops (Artificial Tear) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Eye Drops (Artificial Tear) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Eye Drops (Artificial Tear) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Eye Drops (Artificial Tear) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Eye Drops (Artificial Tear) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Eye Drops (Artificial Tear) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Eye Drops (Artificial Tear) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Eye Drops (Artificial Tear) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Eye Drops (Artificial Tear) Sales (K Units) by Type (2020-2025)
 Table 51. Global Eye Drops (Artificial Tear) Sales (K Units) by Type (2026-2031)
 Table 52. Global Eye Drops (Artificial Tear) Sales Market Share by Type (2020-2025)
 Table 53. Global Eye Drops (Artificial Tear) Sales Market Share by Type (2026-2031)
 Table 54. Global Eye Drops (Artificial Tear) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Eye Drops (Artificial Tear) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Eye Drops (Artificial Tear) Revenue Market Share by Type (2020-2025)
 Table 57. Global Eye Drops (Artificial Tear) Revenue Market Share by Type (2026-2031)
 Table 58. Global Eye Drops (Artificial Tear) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Eye Drops (Artificial Tear) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Eye Drops (Artificial Tear) Sales (K Units) by Application (2020-2025)
 Table 61. Global Eye Drops (Artificial Tear) Sales (K Units) by Application (2026-2031)
 Table 62. Global Eye Drops (Artificial Tear) Sales Market Share by Application (2020-2025)
 Table 63. Global Eye Drops (Artificial Tear) Sales Market Share by Application (2026-2031)
 Table 64. Global Eye Drops (Artificial Tear) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Eye Drops (Artificial Tear) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Eye Drops (Artificial Tear) Revenue Market Share by Application (2020-2025)
 Table 67. Global Eye Drops (Artificial Tear) Revenue Market Share by Application (2026-2031)
 Table 68. Global Eye Drops (Artificial Tear) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Eye Drops (Artificial Tear) Price (US$/Unit) by Application (2026-2031)
 Table 70. Allergan Company Information
 Table 71. Allergan Description and Business Overview
 Table 72. Allergan Eye Drops (Artificial Tear) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Allergan Eye Drops (Artificial Tear) Product
 Table 74. Allergan Recent Developments/Updates
 Table 75. Alcon Company Information
 Table 76. Alcon Description and Business Overview
 Table 77. Alcon Eye Drops (Artificial Tear) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Alcon Eye Drops (Artificial Tear) Product
 Table 79. Alcon Recent Developments/Updates
 Table 80. Novartis Company Information
 Table 81. Novartis Description and Business Overview
 Table 82. Novartis Eye Drops (Artificial Tear) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Novartis Eye Drops (Artificial Tear) Product
 Table 84. Novartis Recent Developments/Updates
 Table 85. Santen Pharma Company Information
 Table 86. Santen Pharma Description and Business Overview
 Table 87. Santen Pharma Eye Drops (Artificial Tear) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Santen Pharma Eye Drops (Artificial Tear) Product
 Table 89. Santen Pharma Recent Developments/Updates
 Table 90. Johnson & Johnson Company Information
 Table 91. Johnson & Johnson Description and Business Overview
 Table 92. Johnson & Johnson Eye Drops (Artificial Tear) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Johnson & Johnson Eye Drops (Artificial Tear) Product
 Table 94. Johnson & Johnson Recent Developments/Updates
 Table 95. Bausch & Lomb Company Information
 Table 96. Bausch & Lomb Description and Business Overview
 Table 97. Bausch & Lomb Eye Drops (Artificial Tear) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Bausch & Lomb Eye Drops (Artificial Tear) Product
 Table 99. Bausch & Lomb Recent Developments/Updates
 Table 100. Thea pharmaceuticals Company Information
 Table 101. Thea pharmaceuticals Description and Business Overview
 Table 102. Thea pharmaceuticals Eye Drops (Artificial Tear) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Thea pharmaceuticals Eye Drops (Artificial Tear) Product
 Table 104. Thea pharmaceuticals Recent Developments/Updates
 Table 105. URSAPHARM Company Information
 Table 106. URSAPHARM Description and Business Overview
 Table 107. URSAPHARM Eye Drops (Artificial Tear) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. URSAPHARM Eye Drops (Artificial Tear) Product
 Table 109. URSAPHARM Recent Developments/Updates
 Table 110. SIMILASAN Company Information
 Table 111. SIMILASAN Description and Business Overview
 Table 112. SIMILASAN Eye Drops (Artificial Tear) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. SIMILASAN Eye Drops (Artificial Tear) Product
 Table 114. SIMILASAN Recent Developments/Updates
 Table 115. Akorn Company Information
 Table 116. Akorn Description and Business Overview
 Table 117. Akorn Eye Drops (Artificial Tear) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Akorn Eye Drops (Artificial Tear) Product
 Table 119. Akorn Recent Developments/Updates
 Table 120. United Laboratories Company Information
 Table 121. United Laboratories Description and Business Overview
 Table 122. United Laboratories Eye Drops (Artificial Tear) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. United Laboratories Eye Drops (Artificial Tear) Product
 Table 124. United Laboratories Recent Developments/Updates
 Table 125. Sun Pharmaceutical Company Information
 Table 126. Sun Pharmaceutical Description and Business Overview
 Table 127. Sun Pharmaceutical Eye Drops (Artificial Tear) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Sun Pharmaceutical Eye Drops (Artificial Tear) Product
 Table 129. Sun Pharmaceutical Recent Developments/Updates
 Table 130. Jianfeng Group Company Information
 Table 131. Jianfeng Group Description and Business Overview
 Table 132. Jianfeng Group Eye Drops (Artificial Tear) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Jianfeng Group Eye Drops (Artificial Tear) Product
 Table 134. Jianfeng Group Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Eye Drops (Artificial Tear) Distributors List
 Table 138. Eye Drops (Artificial Tear) Customers List
 Table 139. Eye Drops (Artificial Tear) Market Trends
 Table 140. Eye Drops (Artificial Tear) Market Drivers
 Table 141. Eye Drops (Artificial Tear) Market Challenges
 Table 142. Eye Drops (Artificial Tear) Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Eye Drops (Artificial Tear)
 Figure 2. Global Eye Drops (Artificial Tear) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Eye Drops (Artificial Tear) Market Share by Type: 2024 & 2031
 Figure 4. Allergy Eye Care Product Picture
 Figure 5. Standard Eye Care Product Picture
 Figure 6. Global Eye Drops (Artificial Tear) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Eye Drops (Artificial Tear) Market Share by Application: 2024 & 2031
 Figure 8. Pharmacy
 Figure 9. Internet
 Figure 10. Grocery
 Figure 11. Optical Chains
 Figure 12. Global Eye Drops (Artificial Tear) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Eye Drops (Artificial Tear) Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Eye Drops (Artificial Tear) Sales (2020-2031) & (K Units)
 Figure 15. Global Eye Drops (Artificial Tear) Average Price (US$/Unit) & (2020-2031)
 Figure 16. Eye Drops (Artificial Tear) Report Years Considered
 Figure 17. Eye Drops (Artificial Tear) Sales Share by Manufacturers in 2024
 Figure 18. Global Eye Drops (Artificial Tear) Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Eye Drops (Artificial Tear) Players: Market Share by Revenue in Eye Drops (Artificial Tear) in 2024
 Figure 20. Eye Drops (Artificial Tear) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Eye Drops (Artificial Tear) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Eye Drops (Artificial Tear) Sales Market Share by Country (2020-2031)
 Figure 23. North America Eye Drops (Artificial Tear) Revenue Market Share by Country (2020-2031)
 Figure 24. United States Eye Drops (Artificial Tear) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Eye Drops (Artificial Tear) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Eye Drops (Artificial Tear) Sales Market Share by Country (2020-2031)
 Figure 27. Europe Eye Drops (Artificial Tear) Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Eye Drops (Artificial Tear) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Eye Drops (Artificial Tear) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Eye Drops (Artificial Tear) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Eye Drops (Artificial Tear) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Eye Drops (Artificial Tear) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Eye Drops (Artificial Tear) Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Eye Drops (Artificial Tear) Revenue Market Share by Region (2020-2031)
 Figure 35. China Eye Drops (Artificial Tear) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Eye Drops (Artificial Tear) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Eye Drops (Artificial Tear) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Eye Drops (Artificial Tear) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Eye Drops (Artificial Tear) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Eye Drops (Artificial Tear) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Eye Drops (Artificial Tear) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Eye Drops (Artificial Tear) Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Eye Drops (Artificial Tear) Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Eye Drops (Artificial Tear) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Eye Drops (Artificial Tear) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Eye Drops (Artificial Tear) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Eye Drops (Artificial Tear) Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Eye Drops (Artificial Tear) Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Eye Drops (Artificial Tear) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Eye Drops (Artificial Tear) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Eye Drops (Artificial Tear) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Eye Drops (Artificial Tear) by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Eye Drops (Artificial Tear) by Type (2020-2031)
 Figure 54. Global Eye Drops (Artificial Tear) Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Eye Drops (Artificial Tear) by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Eye Drops (Artificial Tear) by Application (2020-2031)
 Figure 57. Global Eye Drops (Artificial Tear) Price (US$/Unit) by Application (2020-2031)
 Figure 58. Eye Drops (Artificial Tear) Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Artificial Tears and Lubricants Market Research Report 2025
Global Artificial Tears Market Research Report 2025
Global Eye Drops and Lubricants Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
OTC Artificial Tears Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Artificial Tears Lubricating Eye Drop Market Research Report 2024
Global Artificial Tear For Dry Eye Treatment Market Research Report 2024
Lubricating Eye Drops for Dry Eyes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hyaluronic Acid Eye Drops Market Research Report 2024
Global Dry Eye Syndrome Eye Drops Market Research Report 2024
Preservative Free Artificial Tear Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Conjunctivitis Treatment Eye Drops Market Research Report 2024
Global Sodium Hyaluronate Eye Drops Market Insights Forecast to 2030
Global Dry Eye Medications Market Research Report 2024
Global Eye Drops for Contact Lens Market Research Report 2024
Global Dry or Tired Eye Drops Market Research Report 2024
Global Polyethylene Glycol Eye Drops Market Research Report 2024
Global Glaucoma Eye Drops Market Research Report 2024
Global Dry Eye Relief Eye Drops Market Research Report 2024
Global Disposable Eye Drops Market Research Report 2024
Global Eye Drops Lubricants Market Insights Forecast to 2030

RELATED REPORTS

Global High Acuity Care Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5D18285
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global mHealth (Mobile Health) Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18B6151
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Resin Lenses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21S7871
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mobile Medical Imaging Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16Q6154
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions